BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2003
View Archived Issues
Three series of antitumor agents prepared and tested at Synta
Read More
First-quarter development at Esperion
Read More
Roche patents retinoid receptor agonists for emphysema and other uses
Read More
Novel tyrosine kinase inhibitors under study at Merck & Co.
Read More
GSK researchers describe new beta2-adrenoceptor agonists for use in respiratory disorders
Read More
New GSK-3 inhibitor with utility in diabetes therapy
Read More
Aventis scientists identify novel protein kinase inhibitors
Read More
Novo Nordisk and Boehringer Ingelheim describe new histamine H3 receptor modulators
Read More
New antidiabetic agents in early development at Merck KGaA
Read More
Novel modulators of LPA receptors and their use in cancer, wound healing, etc.
Read More
New iGluR5 antagonists in Lilly development pipeline
Read More
Procyon completes acquisition of Pharmacor
Read More
EyeTech enters Xalatan commercialization agreement with Pfizer
Read More
Arrow's RSV compound enters preclinical testing
Read More
Initiation of phase I/II study of CG-7870 plus radiation in early-stage prostate cancer
Read More
Diatos licenses European rights for Super-Leu-Dox
Read More
ISIS-23722 selected for clinical development
Read More
Microscience develops oral anthrax vaccine
Read More
FDA approves Oxycyte clinical protocol
Read More
Positive results from second phase III trial of immediate-release indiplon
Read More
Phase II Oxytrex study completes enrollment
Read More
Ilomastat successful in treating exposure to mustard gas
Read More
FTY-720 protects rats against experimental autoimmune encephalomyelitis
Read More
Neurokinin NK1 receptor antagonism prevents cytokine-mediated liver injury
Read More
NIH licensing opportunity: method of promoting T-cell migration to tumor vasculature
Read More
sFRP and peptide motifs that interact with sFRP and methods of use available for licensing from NIH
Read More